Faculty

Emily Blumberg, M.D.

Dr. Blumberg specializes in infectious disease complications of solid organ transplantation. She is responsible for infectious diseases consultation in this population, which includes recipients of heart, liver, lung, kidney, and pancreas transplant and participates in related clinical research. Current research interests include transplantation in HIV infected individuals, use of newer antimicrobial agents in transplant recipients, and infections in patients with ventricular assist devices.

Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus (VRE) in patients awaiting liver transplantation. Am J Transplant 3:902-905, 2003

Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD. Efficacy and safety of valganciclovir vs oral ganciclovir for prevention of CMV disease in transplant recipients. American Journal of Transplantation 4:611-20, 2004

Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E.  Determinants of transplant surgeons’ willingness to provide organs to patients infected with Hepatitis B, Hepatitis C, or Human Immunodeficiency Viruses. American Journal of Transplantation 5:1319-25, 2005

Gasink LB, Blumberg EA, Localio AR, Desai SS, Israni AK, Lautenbach E. The impact of donor hepatitis C virus seropositivity on survival in heart transplant recipients. JAMA 2006;296:1843-50.

Contact:
Emily Blumberg, M.D.
Suite E, 3 Silverstein,3400 Spruce Street
Philadelphia, PA 19104-4283
blumbere@mail.med.upenn.edu
(215) 662-7066